Table 2.
Variables | Number (n=126) | Percent |
Types of vasculitis | ||
Polymyalgia rheumatica/giant cell arteritis | 28 | 22.2 |
Granulomatosis with polyangiitis | 26 | 20.6 |
Cutaneous small-vessel vasculitis | 15 | 11.9 |
Undifferentiated vasculitis | 15 | 11.9 |
Takayasu arteritis | 12 | 9.5 |
Polyarteritis nodosa | 10 | 7.9 |
Eosinophilic granulomatosis with polyangiitis | 6 | 4.8 |
Hypocomplementemic urticarial vasculitis | 5 | 4.0 |
IgA vasculitis | 4 | 3.2 |
Microscopic Polyangiitis | 4 | 3.2 |
Central nervous system vasculitis | 1 | 0.8 |
Disease duration (months) | 37.72±18.1 | - |
Clinical manifestations | ||
General symptoms | 74 | 58.7 |
Cutaneous and mucous membranes involvement | 57 | 45.2 |
Ophthalmic involvement | 10 | 7.9 |
Ears, nose and throat involvement | 26 | 20.6 |
Pulmonary involvement | 25 | 19.8 |
Cardiovascular system involvement | 19 | 15.1 |
Abdominal involvement | 6 | 4.8 |
Renal involvement | 40 | 31.7 |
Nervous System involvement | 41 | 32.5 |
BVAS | 10.6 (1-36) | - |
BVAS: Birmingham Vasculitis Activity Score.
Data were displayed as numbers (percentages), means ± SD or median (Min-Max), as appropriate